Avisa Myko Inc  logo — Soluble Natural Melanin , 4000x cheaper

Avisa Myko Inc

Soluble Natural Melanin , 4000x cheaper

Founded 2019 United States San Francisco, United States 5 employees Convertible Note Biotechnology, Manufacturing +2

General Information

Company Name Avisa Myko Inc
Founded Year 2019
Location United States San Francisco, United States +1
Employees 5
Industries Biotechnology, Manufacturing, Medical Devices +1
Funding Stage Convertible Note
Social

Get notified when Avisa Myko Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Avisa Myko Inc

Avisa Myko Inc is a biotechnology and manufacturing startup based in the United States, founded in 2019. The company has developed a unique and cost-effective fermentation technology to produce Natural Melanin, which is 4000 times cheaper than the current market cost. Avisa Myko aims to disrupt the industry by offering a cost-efficient solution with various applications in cosmetics, pharma, and industrial settings, including rechargeable magnesium ion and sodium ion batteries. The company has no direct competitors for its Black Eumelanin technology, positioning itself as a pioneering player in the market. Avisa Myko has received seed funding from prominent investors including SOSV, Indiebio Accelerator, Advisors Fund, and VII Ventures. The latest investment was a Seed Round investment on 09 August 2023 led by SOSV and Indiebio. With its focus on eco-friendly solutions, Avisa Myko addresses the environmental concerns associated with sunscreen use. By utilizing melanin as a UV blocker, the company seeks to replace damaging chemicals and nano minerals in sunscreen formulations, offering a biodegradable, non-toxic, and reef-safe alternative. This approach aligns with the growing demand for sustainable products in the $12 billion sunscreen industry. In addition to sunscreen applications, Avisa Myko is exploring other potential uses for melanin, catering to various industries. The innovative technology and the potential to address critical environmental and cost-related challenges make Avisa Myko an intriguing prospect for investors looking to capitalize on disruptive solutions in biotechnology and manufacturing.

Taxonomy: Melanin production, Fermentation technology, Cosmetics industry, Pharmaceutical industry, Industrial applications, Rechargeable batteries, Eumelanin technology, Sunscreen innovation, UV blocker, Eco-friendly products, Reef safe products, Non-toxic materials, Seed funding, Indiebio Accelerator, SOSV

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 2
Investor Investor
23 Feb 2024
Seed Round •••••• 2
Investor Investor
09 Aug 2023
Convertible Note •••••• 2
Investor Investor
18 Feb 2022
Non Equity Assistance •••••• 1
Investor
07 Apr 2021
Seed Round •••••• 2
Investor Investor
25 Sep 2019

FAQ About Avisa Myko Inc

Soluble Natural Melanin , 4000x cheaper
Avisa Myko Inc was founded in 2019.
Avisa Myko Inc is headquartered in San Francisco, United States.
Avisa Myko Inc operates in the following industries: Biotechnology, Manufacturing, Medical Devices, Semiconductor.
Avisa Myko Inc has approximately 5 employees.
Avisa Myko Inc has completed 5 funding rounds. The latest funding stage is Convertible Note.

We're actively collecting intelligence on Avisa Myko Inc .

Track Avisa Myko Inc to get notified

Don't just browse. Track.

Signal Tracker monitors Avisa Myko Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes